Clinical Safety and Efficacy Study of Water Flosser in Enhancing Oral Health Among Healthy Adults Having Plaque-induced Gingivitis and Dental Plaque Accumulation
A Double-Blind, Randomized, Control-Arm Clinical Study to Evaluate the Safety and Efficacy of Test Water Flosser in Enhancing Oral Health Among Healthy Adults Having Plaque-Induced Gingivitis and Dental Plaque Accumulation
1 other identifier
interventional
64
0 countries
N/A
Brief Summary
This is a double-blind, randomized, control-arm clinical study to evaluate safety and efficacy of test water flosser in enhancing oral health among healthy adults having plaque-induced gingivitis and dental plaque accumulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2025
CompletedFirst Posted
Study publicly available on registry
October 3, 2025
CompletedStudy Start
First participant enrolled
November 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2025
CompletedNovember 10, 2025
November 1, 2025
Same day
September 24, 2025
November 6, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
To assess the effectiveness of the test product in terms of change in plaque deposition
By using Turesky Modification of the Quigley-Hein Index by Dentist or Dentist trained evaluator.
Before and after usage of test product at T30 mins on Day 01, Day 15 (±2 days), and Day 30 (±2 days)
To assess the effectiveness of the test product in terms of change in plaque induced gingivitis
By using Loe \& Silness Gingival Index by Dentist or Dentist trained evaluator.
Before and after usage of test product at T30 mins on Day 01, Day 15 (±2 days), and Day 30 (±2 days)
Secondary Outcomes (1)
To assess the improvement in product perception questionnaire
Baseline prior to usage of test product and on Day 01, Day 15 (±2 days), and Day 30 (±2 days)
Other Outcomes (1)
Safety assessment by examined of oral soft tissues (tongue, hard and soft palate, gingivae, mucobuccal folds, inner cheeks, sublingual areas) and hard tissues, including dental restorations.
At baseline Day 01 (±2 days), Day 15 (±2 days), and Day 30 (±2 days)
Study Arms (2)
Gurunanda - Water Flosser
EXPERIMENTALMode of Usage: Follow the below listed steps for product usage post brushing of teeth. 1. Fill - Add water to the tank of the Flosser 2. Insert - Add the tip to the flosser 3. Select - Choose the level of pressure 4. Floss - Guide the stream between your teeth and along the gumline 5. Clean - After use, insert the tip in the water tank and sanitize Frequency: Use twice a day after brushing. Route of administration: Topical - Oral Storage Condition: Store in a cool, dry place, away from direct sunlight, and do not submerge in water.
No water Flossing
EXPERIMENTALInterventions
Mode of Usage: Follow the below listed steps for product usage post brushing of teeth. 1. Fill - Add water to the tank of the Flosser 2. Insert - Add the tip to the flosser 3. Select - Choose the level of pressure 4. Floss - Guide the stream between your teeth and along the gumline 5. Clean - After use, insert the tip in the water tank and sanitize Frequency: Use twice a day after brushing. Route of administration: Topical - Oral Storage Condition: Store in a cool, dry place, away from direct sunlight, and do not submerge in water.
Eligibility Criteria
You may qualify if:
- Age: 18 to 65 years (both inclusive) old at the time of consent.
- Sex: Healthy adult males and non-pregnant/non-lactating females.
- Females of childbearing potential have a self-reported negative urine pregnancy test at the time of the screening visit and agree to follow an accepted method of birth control for the duration of the study such as condoms, foams, jellies, diaphragm, intrauterine device etc.
- Subjects are generally in good general health as determined from recent medical history.
- Subjects with mild to moderate gingivitis and good oral health, without hard or soft tissue lesions, with moderate gingivitis characterized by more than 30% bleeding sites and probing depths of ≤3 mm without attachment loss.
- Anterior teeth without restorations.
- No dental treatments being performed before or during the study period.
- Possessing at least 20 permanent teeth (excluding the third molars) and 5 evaluable teeth in each quadrant.
- Subjects who agree to discontinue the use of over-the-counter any teeth products throughout the trial except for the ADA-approved toothbrush and toothpaste provided during the study.
- Subjects who agree to refrain from the use of any other type of floss or similar dental product during the study.
- Agree not to participate in any other oral/dental product studies during the trial.
- Agree to return for all scheduled visits and follow study procedures.
- Subjects who are willing to complete all study procedures including study-related questionnaires and comply with study requirements.
You may not qualify if:
- Subjects who are undergoing treatment for gingivitis, caries, dental plaque and sensitivity.
- Subjects are present with fixed orthodontic appliances on the facial surfaces of the maxillary arch.
- Subjects have dental crowns, veneers or composite restorations on gradable maxillary anterior teeth (canine to canine) or mandibular anterior teeth.
- Subjects have any oral pathologies or gross neglect of home care requiring prompt treatment, including periodontal disease, as evidenced by purulent exudate, tooth mobility, and/or other signs indicating that the integrity of the data collected for that subject might be compromised.
- Subjects are present with any pre-existing oral or medical condition that the Investigator/designee determines may place the subject at increased health risk from study participation.
- Suffering from untreated dental caries, mucosal lesions, oral tumors or severe systemic diseases that may affect periodontal diseases.
- Subjects have any known allergies to over-the-counter oral hygiene/products.
- Subjects have any known allergies to the trial product ingredients.
- The subject must have participated in a clinical study with oral care or oral hygiene within 4 weeks before the screening visit of this study.
- Subjects who smoke and are pan eaters.
- Subjects with hypersensitive teeth.
- Subjects having chipped teeth and defective restorations.
- Subjects having deep periodontal pockets.
- Subjects having bridgework in their teeth and dentures which interrupt during evaluation.
- Subjects undergoing treatment with antibiotics, anti-inflammatory, anticonvulsants, anti-histaminic, anti-depressant, anti-histaminic, sedatives, tranquilizers or daily analgesic drugs.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NovoBliss Research Pvt Ltdlead
- GuruNanda LLCcollaborator
Study Officials
- STUDY DIRECTOR
Nayan Patel
NovoBliss Research Pvt Ltd
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2025
First Posted
October 3, 2025
Study Start
November 13, 2025
Primary Completion
November 13, 2025
Study Completion
December 6, 2025
Last Updated
November 10, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share